Top Stories
-
Twenty years ago, when AIDS was devastating communities in sub-Saharan Africa, Columbia's Wafaa El-Sadr created an organization to save lives in some of the continent’s hardest-hit countries.
Topic
-
Two new monoclonal antibodies are prime candidates for development into new COVID drugs for people with weak immune systems.
Topic
-
A new study published in Nature offers reassuring data on the updated COVID vaccines.
Topic
-
Quick fixes are not the answer when seeking ways to boost your immunity or increase your protection against infection.
Topic
Latest News
- October 17, 2014
Rat population of New York City carries variety of disease-causing microbes.
Topic
- October 6, 2014
Columbia Nursing confronts the Ebola outbreak, a tragic, textbook example of a public health crisis.
Topic
- August 5, 2014
CUMC experts in infectious disease and public health are keeping the public informed about the outbreak and the potential of the virus to spread.
Topic
-
Source:
The Wall Street JournalAugust 4, 2014Topic
- July 9, 2014
The new 2014 Irving Scholars are Siddhartha Mukherjee, Carolyn Rodriguez, Bret Rutherford, and Anne-Catrin Uhlemann.
Topic
- June 23, 2014
A Columbia Nursing study found that eHealth interventions are associated with reductions in risky sexual behaviors and increases in HIV testing among men who have sex with men.
Topic
- May 30, 2014
P&S systems biologists dive into huge databases of genomes, proteins, and metabolites to find new ways to target the world’s most deadly pathogens.
Topic
- May 29, 2014
Kawasaki disease, the leading cause of acquired heart disease in children, may be caused by fungal particles or toxins carried on wind currents from northeastern China to Japan.
Topic
- May 5, 2014
A New England Journal of Medicine Perspective calls for academic institutions to foster research in implementation science and advance research to confront global challenges.
Topic
- May 2, 2014
New, more definitive evidence implicates camels in the ongoing outbreak of Middle East Respiratory Syndrome, or MERS.
Topic
